期刊
EXPERT OPINION ON DRUG DELIVERY
卷 15, 期 6, 页码 559-566出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2018.1472570
关键词
Topical delivery; Er:YAG laser; fractional laser ablation; epidermis; living cells; cell therapy; skin
资金
- Swiss Commission for Technology and Innovation [9307.1 PFLS-LS]
- National Natural Science Foundation of China [31200640/C0508, 21135004/B050901]
- Pantec Biosolutions AG
Background: Dermatological diseases, including most skin cancers and rare genetic conditions frequently originate in the epidermis. Targeted, topical cell-based therapy is a promising therapeutic strategy. Here, we present the first report demonstrating that fractional laser ablation enables local needle-free' intraepidermal delivery of living human cells. Methods: The cells penetrated porcine ear skin via microchannels created by Er:YAG fractional laser ablation; cell delivery was quantified using a haemocytometer. Cutaneous distribution was confirmed visually by laser scanning confocal microscopy and histological analysis. Results: Total cell delivery (sum of amounts permeated and deposited) after 24h increased from 5.7 +/- 0.1 x 10(5) to 9.6 +/- 1.6 x 10(5)cells/cm(2) when increasing pore density from 300 to 600pores/cm(2), - corresponding to 19- and 32-fold increases over the control. At 600pores/cm(2), cell deposition was 136-fold greater than cell permeation - the latter most likely due to transport from micropores into appendageal pathways. Production of GFP post-delivery confirmed cell remained viability. Conclusion: The results demonstrate the feasibility of using controlled laser microporation to achieve local needle-free' cutaneous delivery of living human cells to the epidermis and dermis. This raises the possibility of using this technique for targeted new approaches for dermatological therapy in these regions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据